DGCI

DGCI Approved Biocon's CytoSorb for COVID-19 Treatment

This is an extracorporeal blood purification (EBP) device which can help reduce pro-inflammatory cytokines levels in confirmed COVID-19 patients admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure.

By SMEStreet Desk

May 22, 2025 18:20 IST logo

1 Min read

LimeLight

Anti-COVID Drug by DRDO Gets DCGI's Approval

By SMEStreet Edit Desk

May 08, 2021 12:11 IST logo

3 Min read

News

DCGI Explained Emergency Approval of COVID-19 Virus Vaccine

By SMEStreet Edit Desk

Jan 04, 2021 04:34 IST logo

3 Min read

Dr Harsh Vardhan, COVID-19, WHO, COVID Testing

News

DCGI Approves Phase II+III Trials of Oxford University Vaccine by Serum Institute

By SMEStreet Desk

Aug 03, 2020 11:11 IST logo

1 Min read

Glenn Saldahna, Stock Market, BSE, Glenmark Pharmaceuticals, USFDA, Acid Reflux

News

Glenmark’s Favipiravir is Different from Livealth Bio Pharma’s Livfavir

By SMEStreet Desk

Jun 25, 2020 09:45 IST logo

2 Min read

Sectors

Sun Pharma's AQCH - Phytopharmaceutical Drug Goes into Phase 2 Clinical Trial for COVID-19 Treatment

By SMEStreet Desk

Jun 05, 2020 08:02 IST logo

2 Min read

News

Sun Pharma Gets DGCI's Approval for Nafamostat Mesilate Clinical Trials on COVID-19 Patients

By SMEStreet Desk

May 29, 2020 11:53 IST logo

2 Min read